The client diagnosed with diabetes insipidus (DI) is receiving desmopressin (DDAVP), a pituitary hormone, intranasally. Which assessment data warrants the client notifying the health-care provider?...

The client diagnosed with diabetes insipidus (DI) is receiving desmopressin (DDAVP), a pituitary hormone, intranasally. Which assessment data warrants the client notifying the health-care provider? Select all that apply.

1. The client does not feel thirsty all the time.

2. The client is able to sleep throughout the night.

3. The client has gained 2 kg in the past 24 hours.

4. The client has to urinate 20–30 times daily.

5. The client has elastic skin turgor and moist mucosa.